Professor Daniel Globisch
ORCID: 
Google Scholar: 
Education and Professional Research:
2015 – present: Uppsala University, Uppsala 
2020 – present: Center for Translational Microbiome Research (CTMR)
Guest affiliation at Karolinska Institute, Stockholm
2011 – 2015: The Scripps Research Institute (TSRI), La Jolla, CA 
Laboratory of Professor Kim D. Janda
2007 – 2011: Ludwig Maximilians University (LMU) Munich 
Laboratory of Professor Thomas Carell
2006 – 2007: University of Southern Denmark, Odense 
2001 – 2006: Technical University of Kaiserslautern
Short Biography
Full Professor Daniel Globisch started his independent research group in 2015 at Uppsala University as a Science For Life Laboratory Fellow. He joined the Department of Medicinal Chemistry and has been appointed as Associate Professor in 2017. In 2020, Daniel Globisch received tenure and moved with his laboratory to the Department of Chemistry – BMC, where he has been promoted to Full Professor in 2023. He also has a guest affiliation at the Center for Translational Microbiome Research (CTMR) at Karolinska Institute since 2020.
At Uppsala University, his laboratory develops new Chemical Biology methodologies to extend the scope of metabolomics research to discover new biomarkers for pancreatic and colorectal cancer. The interdisciplinary nature of the research projects is focused on elucidation of the metabolic interaction between the gut microbiota and their human host. Daniel Globisch has been awarded research grants from the Swedish Research Council (Vetenskåpsradet), the Swedish Cancer Foundation, the Brain Foundation, SciLifeLab, Carl-Tryggers-Foundation and is part of four international EU projects (COLOTAN, Re-MEND, PANCAID, and MetaboAD). Daniel has been elected as a board member of the Nordic Metabolomics Society in 2019 for two terms.
Daniel studied Chemistry at the Technical University of Kaiserslautern (Germany). He completed his Master’s thesis in Organic Chemistry at the Southern University of Denmark in Odense. Daniel defended his PhD thesis in Organic Chemistry and Chemical Biology in 2011 at the Ludwig-Maximilians-University in Munich. He joined The Scripps Research Institute to develop Chemical Biology strategies for the inhibition of bacterial quorum sensing holding a postdoctoral research grant from the German Academic Exchange Service (DAAD) (2011-2015). During his postdoctoral research, Daniel Globisch discovered the biomarker N-acetyltyramine-O-glucuronide (NATOG) using a metabolomics mining approach for the neglected tropical disease onchocerciasis within the Worm Institute for Research and Medicine (WIRM), for which a lateral flow diagnostic has been developed.